Assessing the association between global structural brain age and polygenic risk for schizophrenia in early adulthood: a recall-by-genotype study
Constantinides, C; Baltramonaityte, V; Caramaschi, D; et al.Han, LKM; Lancaster, TM; Zammit, S; Freeman, TP; Walton, E
Date: 8 December 2023
Article
Journal
Cortex
Publisher
Elsevier
Publisher DOI
Related links
Abstract
Neuroimaging studies consistently show advanced brain age in schizophrenia, suggesting that brain structure is often ‘older’ than expected at a given chronological age. Whether advanced brain age is linked to genetic liability for schizophrenia remains unclear. In this pre-registered secondary data analysis, we utilised a recall-by-genotype ...
Neuroimaging studies consistently show advanced brain age in schizophrenia, suggesting that brain structure is often ‘older’ than expected at a given chronological age. Whether advanced brain age is linked to genetic liability for schizophrenia remains unclear. In this pre-registered secondary data analysis, we utilised a recall-by-genotype approach applied to a population-based subsample from the Avon Longitudinal Study of Parents and Children to assess brain age differences between young adults aged 21-24 years with relatively high (n=96) and low (n=93) polygenic risk for schizophrenia (SCZ-PRS). A global index of brain age (or brain-predicted age) was estimated using a publicly available machine learning model previously trained on a combination of region-wise gray-matter measures, including cortical thickness, surface area and subcortical volumes derived from T1-weighted magnetic resonance imaging (MRI) scans. We found no difference in mean brain PAD (the difference between brain-predicted age and chronological age) between the high- and low- SCZ-PRS groups, controlling for the effects of sex and age at time of scanning (b = - 0.21;
95% CI -2.00, 1.58; p = 0.82; Cohen’s d = - 0.03; partial R2
= 0.00029). These findings do not support an association between SCZ-PRS and brain-PAD based on global age-related structural brain patterns, suggesting that brain age may not be a vulnerability marker of common genetic risk for SCZ. Future studies with larger samples and multimodal brain age measures could further investigate global or localised effects of SCZ-PRS.
Psychology
Faculty of Health and Life Sciences
Item views 0
Full item downloads 0
Except where otherwise noted, this item's licence is described as © 2023 The Author(s). Published by Elsevier Ltd. Open access under the Creative Commons Attribution 4.0 International licence